MedPath

Administration Method of Cognitive Screening in Older Individuals With Hearing Loss

Not Applicable
Completed
Conditions
Cognitive Impairment
Hearing Loss, Sensorineural
Interventions
Other: Auditory amplified
Other: Visual
Other: Auditory unamplified
Registration Number
NCT03402932
Lead Sponsor
Northwestern University
Brief Summary

The objectives of the current project aim to determine whether a more controlled amplification method or a visual administration has an effect on hearing impaired older individuals' cognitive test scores.

Detailed Description

Aim 1 is to create a visually administered condition of a cognitive test and to validate this condition in comparison to the auditory administration. Data will be collected from younger individuals with normal hearing. Each younger individual is tested using both visual and auditory condition and the scores are compared across the two conditions. It is anticipated that the scores will not be significantly different between the two conditions.

Aim 2 is to examine the test condition effect on cognitive testing results in older individuals with hearing loss. The three test conditions include auditory unamplified, auditory amplified, and visual. Each older individual will be tested using two different test conditions. It is predicted the auditory amplified and visual administrations will alleviate the cognitive load associated with hearing difficulty and lead to improved performance on the test.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Have sensorineural hearing loss
  • Have normal or corrected-to-normal vision
Read More
Exclusion Criteria
  • Have conductive hearing loss;
  • Have history of otologic or neurologic disorders
  • Have dementia
  • Non-native speakers of English
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Auditory Amplified-VisualAuditory amplifiedThis arm is designed to test the contrast between auditory amplified and visual conditions.
Younger control groupVisualThis arm is designed to validate the visual version by comparing to the auditory version in a group of younger normal hearing controls.
Auditory Amplified-UnamplifiedAuditory unamplifiedThis arm is designed to test the contrast between auditory amplified and unamplified conditions.
Auditory Unamplified-VisualVisualThis arm is designed to test the contrast between auditory unamplified and visual conditions.
Auditory Amplified-VisualVisualThis arm is designed to test the contrast between auditory amplified and visual conditions.
Auditory Unamplified-VisualAuditory unamplifiedThis arm is designed to test the contrast between auditory unamplified and visual conditions.
Auditory Amplified-UnamplifiedAuditory amplifiedThis arm is designed to test the contrast between auditory amplified and unamplified conditions.
Younger control groupAuditory unamplifiedThis arm is designed to validate the visual version by comparing to the auditory version in a group of younger normal hearing controls.
Primary Outcome Measures
NameTimeMethod
Cognitive Screening Results (Montreal Cognitive Assessment)The outcome measure was assessed immediately after the test. This applies to both conditions for all the arms.

The cognitive screening test of Montreal Cognitive Assessment (MoCA) was administered to 4 groups with different administration method conditions (see arms/groups table).

MoCA is s standardized cognitive screening tool for mild cognitive impairment and dementia. The total score was used as outcome measure of this study and this score ranges from 0-30, with higher score being better performance.

Secondary Outcome Measures
NameTimeMethod
Auditory Working Memory PerformanceThe outcome measure will be assessed immediately after the test.

Older individuals were presented with lists of words and instructed to repeat them back. After each word list, they had to recall the words.

Trial Locations

Locations (1)

Hearing Aid Laboratory

🇺🇸

Evanston, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath